(NASDAQ: JAN) JANONE INC. shares popped up 40% on news this morning. Shares are surging at $3.48 as traders have more than 30,000 trades on heavy volume.

(NASDAQ: JAN) JANONE INC. shares popped up 40% on news this morning. Shares are surging at $3.48 as traders have more than 30,000 trades on heavy volume.

LAS VEGAS, June 7, 2022 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced today that a patent was issued that covers a method of improving nerve function using JAN101. JAN101 (formerly known as TV1001SR), is a potential treatment for peripheral artery disease (PAD), a vascular disease that affects more than 8.5 million people in the U.S. and more than 60 million people worldwide.

https://ir.janone.com/news-events/press-releases/detail/44/janone-inc-announces-the-issuance-of-u-s-patent-covering

Signup today for free and be the first to get notified of breaking news.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist